Margaret Dalesandro - Sep 14, 2021 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ Margaret Dalesandro
Stock symbol
SKYE
Transactions as of
Sep 14, 2021
Transactions value $
$0
Form type
4
Date filed
9/16/2021, 04:04 PM
Previous filing
Sep 2, 2021
Next filing
Jan 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SKYE Director Stock Option (Right to Buy) Award $0 +150K +60% $0.00 400K Sep 14, 2021 Common Stock 150K $0.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option shall be exercisable for a price of $0.12 per Option Share in twelve equal monthly installments such that all the Option Shares shall vest in twelve months.